ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 171 filers reported holding ASCENDIS PHARMA A/S in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $308,000 | 0.0% | 2,985 | -10.0% | 0.12% | +8.3% |
| Q2 2022 | $308,000 | -20.8% | 3,315 | 0.0% | 0.11% | -10.7% |
| Q1 2022 | $389,000 | -19.0% | 3,315 | -7.0% | 0.12% | -3.2% |
| Q4 2021 | $480,000 | -1.4% | 3,566 | +16.7% | 0.12% | -6.0% |
| Q3 2021 | $487,000 | +15.7% | 3,056 | -4.5% | 0.13% | +11.8% |
| Q2 2021 | $421,000 | +16.9% | 3,200 | +14.7% | 0.12% | +7.2% |
| Q1 2021 | $360,000 | -20.4% | 2,790 | +3.0% | 0.11% | -21.8% |
| Q4 2020 | $452,000 | +10.2% | 2,710 | +1.9% | 0.14% | -5.3% |
| Q3 2020 | $410,000 | +13.3% | 2,660 | +8.6% | 0.15% | +4.9% |
| Q2 2020 | $362,000 | – | 2,450 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 11,225,357 | $1,001,863,112 | 18.92% |
| Q Global Advisors, LLC | 195,000 | $17,404 | 12.55% |
| Sofinnova Investments, Inc. | 754,032 | $67,297,356 | 4.41% |
| Avoro Capital Advisors LLC | 3,580,555 | $319,564,534 | 4.34% |
| Finepoint Capital LP | 139,772 | $12,474,651 | 4.32% |
| Spyglass Capital Management LLC | 657,853 | $58,713,380 | 4.24% |
| Saturn V Capital Management LP | 78,442 | $7,000,948 | 3.88% |
| DAFNA Capital Management LLC | 135,212 | $12,067,671 | 3.30% |
| ARS Investment Partners, LLC | 289,860 | $25,870,005 | 3.02% |
| Ghost Tree Capital, LLC | 100,000 | $8,925,000 | 2.95% |